VVT Med Announces Private Placement of Units

Executive Summary

• VVT Med Inc. announced a non‑brokered private placement of up to 12 million units at $0.25 per unit, targeting gross proceeds of up to $3 million.
• Each unit consists of one common share and half of a common‑share purchase warrant (full warrant allows purchase of an additional share at $0.375 for 24 months).
• Net proceeds are earmarked for expanding U.S. and global commercialization, product manufacturing capacity, working capital and general corporate purposes.

Key Details

• Offering Size: Up to 12,000,000 units (each $0.25) → Gross proceeds up to $3,000,000.
• Unit Composition:
• 1 common share of VVT Med Inc.
• ½ of a common‑share purchase warrant (full warrant = right to buy one additional share at $0.375).
• Warrant Terms: Exercise price $0.375 per share; exercisable for 24 months from issuance.
• Use of Proceeds:
• Expand U.S. and international commercialization efforts.
• Increase product manufacturing capacity to meet anticipated demand.
• Working capital.
• General corporate purposes.
• Holding Period: Securities subject to a four‑month hold period per TSX Venture Exchange rules.
• Regulatory Conditions: Offering contingent on receipt of all required regulatory approvals, including TSX Venture Exchange approval.
• Finder’s Fees: Company may pay finder’s fees in accordance with applicable securities laws and exchange policies.

Notable Quotes

(No direct quotes were included in the release.)